The Lancet Diabetes & Endocrinology

The Lancet Diabetes & Endocrinology launched in September 2013 and is the sixth Lancet specialty journal, following in the footsteps of The Lancet Oncology, The Lancet Neurology, The Lancet Infectious Diseases, The Lancet Respiratory Medicine, and The Lancet Global Health. The journal offers the same unique fast-track experience offered by its sister journals for all authors of research papers that are selected for peer review, whereby articles can be published online within 8 weeks of submission. The Lancet Diabetes & Endocrinology is indexed in PubMed, and has been approved for indexing and abstracting in SciSearch®, Journal Citation Reports, and Current Contents® by Thomson Reuters. Source

Outlet Details

Scope International, Trade/B2B
Language English
Country United Kingdom
UVMs Request pricing
Frequency Bimonthly